There has been a growing interest in predicting in vivo metabolic drug-drug interactions from in vitro systems. High-throughput screening methods aimed at assessing the potential of drug candidates for drug interactions are widely used in industry. However, at present, there is no consensus on metho
β¦ LIBER β¦
559 - In vitro prediction of potential metabolic drug interactions for seroquel
β Scribed by Scott W. Grimm; Karen R. Stams; Khanh Bui
- Book ID
- 119559483
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 119 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0920-9964
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Inhibition-based metabolic drugβdrug int
β
Caiping Yao; RenΓ© H. Levy
π
Article
π
2002
π
John Wiley and Sons
π
English
β 132 KB
Prediction of drug-drug interactions of
β
H. Nakasa; H. Nakamura; S. Ono; M. Tsutsui; M. Kiuchi; S. Ohmori; M. Kitada
π
Article
π
1998
π
Springer
π
English
β 308 KB
Prediction of Drug Metabolism and Intera
β
Olavi Pelkonen; Miia Turpeinen; Jouko Uusitalo; Arja Rautio; Hannu Raunio
π
Article
π
2005
π
John Wiley and Sons
π
English
β 90 KB
Prediction of plasma protein binding dis
β
Hege Christensen; Mark Baker; Geoffrey T. Tucker; Amin Rostami-Hodjegan
π
Article
π
2006
π
John Wiley and Sons
π
English
β 231 KB
π 1 views
Although displacement from plasma protein binding (dPB) is usually of little clinical significance, it should be taken into account when interpreting changes in total plasma concentrations of drugs subject to metabolically based drug-drug interactions (mDDI). The aim of this study was to develop an
Maraviroc: in vitro assessment of drugβd
β
Ruth Hyland; Maurice Dickins; Claire Collins; Hannah Jones; Barry Jones
π
Article
π
2008
π
John Wiley and Sons
π
English
β 785 KB
Database analyses for the prediction of
β
Kiyomi Ito; Hayley S. Brown; J. Brian Houston
π
Article
π
2004
π
John Wiley and Sons
π
English
β 337 KB